Showing 20 of 80 recruiting trials for “idiopathic-pleuroparenchymal-fibroelastosis”
Dose-Escalation Study of Artesunate Patients With IPF
Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial
👨⚕️ Jaume Bordas-Martinez, MD, PhD, Hospital General de Granollers📍 1 site📅 Started Mar 2026View details ↗
Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial
👨⚕️ Jaume Bordas-Martinez, MD, PhD, Hospital General de Granollers📍 1 site📅 Started Mar 2026View details ↗
A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.
👨⚕️ Katerina M. Antoniou, MD PhD, Professor, Department of Respiratory Medicine, University Hospital of Heraklion, School of Medicine, University of Crete📍 1 site📅 Started Jan 2026View details ↗
Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males
A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNS-3545 in Healthy Participants
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis
Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis
Evaluation of the Pulmonary Fibrosis Learning and Self-management Programme (FILIP)
👨⚕️ Thimo Marcin, PHD, Center for Rehabilitation & Sports Medicine Inselspital and Berner Reha Zentrum, Bern University Hospital, University of Bern, Switzerland📍 2 sites📅 Started Oct 2025View details ↗
RecruitingNCT07251725 ↗
GEN-FPF: Genetic Exploration of Familial Pulmonary Fibrosis
RecruitingNCT07332117 ↗
A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications
NAL ER IPF Respiratory Function and Safety Study
Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease
Page 1 of 4Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →